CDIBA
CDIBA is a cytosolic phospholipase A2 (cPLA2) inhibitor. CDIBA inhibits the activation of cPLA2 in rat diaphragm tissue. CDIBA reduces the level of mitochondrial reactive oxygen species in rat diaphragm tissue after prolonged mechanical ventilation. CDIBA attenuates protein degradation, muscle atrophy and decreased muscle strength in the diaphragm of rats after prolonged mechanical ventilation. CDIBA can be used in studies related to ventilator-induced diaphragmatic dysfunction.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 479422-22-5
- 分子式: C31H26ClNO3
- 分子量:496.00
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Phospholipase アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MC9 | Inhibition |
-8 %
Compound: 25
|
Inhibition of PGF2-alpha production in the presence of exogenous arachidonic acid in MC9 cell at 1.5 uM
Inhibition of PGF2-alpha production in the presence of exogenous arachidonic acid in MC9 cell at 1.5 uM
|
[PMID: 16392799] |
| MC9 | Inhibition |
81 %
Compound: 25
|
Inhibition of PGF2-alpha production in MC9 cells at 1.5 uM
Inhibition of PGF2-alpha production in MC9 cells at 1.5 uM
|
[PMID: 16392799] |
| MC9 | Inhibition |
96 %
Compound: 25
|
Inhibition of LTB4 production in MC9 cells at 1.5 uM
Inhibition of LTB4 production in MC9 cells at 1.5 uM
|
[PMID: 16392799] |
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Wistar rats (adult male, SPF level, 450-550 g, ventilator-induced diaphragm dysfunction model)[1]
-
Dosage:30 mg/kg (i.p. injection); 5 mg/kg/h (continuous i.v. infusion)
-
Administration:i.p. (single injection at ventilation onset); i.v. (continuous infusion; 12 hours)
-
Result:Significantly reduced cPLA2 activation in the diaphragm.
Decreased mitochondrial H2O2 production in the diaphragm.
Downregulated diaphragm calpain activity.
Reduced the expression of atrophy-related genes Atrogin-1 and MuRF-1 in the diaphragm.
Increased the cross-sectional area of slow-twitch and fast-twitch diaphragm muscle fibers.
Improved diaphragm contractile function, including increased maximal tetanic forces, elevated force-frequency curve responses, and enhanced fatigue tolerance, compared to untreated ventilated rats.
化学情報
-
CAS 番号 479422-22-5
-
分子量 496.00
-
分子式 C31H26ClNO3
-
SMILES
O=C(O)C1=CC=C(OCCC=2C=3C=C(Cl)C=CC3N(C2C)C(C=4C=CC=CC4)C=5C=CC=CC5)C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- CDIBA
- 479422-22-5
- Phospholipase
- Reactive Oxygen Species (ROS)
- mitochondrial reactive oxygen species
- cytosolic phospholipase A2
- protein degradation
- prolonged mechanical ventilation
- calpain activity
- rat diaphragm tissue
- diaphragm contractile force
- ventilator-induced diaphragm dysfunction
- muscle atrophy
- Inhibitor
- inhibitor
- inhibit